ReviewTheranostics2024

Peptide receptor radionuclide therapy combinations for neuroendocrine tumours in ongoing clinical trials: status 2023.

Gianpaolo di Santo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.